Company Filing History:
Years Active: 2014
Title: The Innovations of Alexander Feick
Introduction
Alexander Feick is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical formulations. His work focuses on improving the efficacy and comfort of treatments for patients.
Latest Patents
Feick holds a patent for "High concentration anti-TNFα antibody liquid formulations." This invention provides a liquid aqueous pharmaceutical formulation that includes a human anti-TNFa antibody or its antigen-binding portion. The formulation is designed to reduce pain associated with injections by at least 50% compared to similar formulations containing salts or buffers. Additionally, it enhances bioavailability when administered subcutaneously, making it a valuable advancement in therapeutic protein delivery.
Career Highlights
Feick is currently employed at AbbVie Biotechnology Ltd., where he continues to innovate in the field of biopharmaceuticals. His work has the potential to significantly improve patient experiences and outcomes in treatments involving anti-TNFα antibodies.
Collaborations
Throughout his career, Feick has collaborated with esteemed colleagues such as Michael Neu and Markus Tschoepe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Alexander Feick's contributions to biotechnology, particularly through his patented formulations, demonstrate his commitment to enhancing patient care. His work at AbbVie Biotechnology Ltd. and collaborations with other professionals highlight the importance of teamwork in driving innovation in the pharmaceutical industry.